ESGCT / SETGYC Annual Congress

93 days

0 hours

56 mins

Post-doctoral position at Boehringer Ingelheim in Biberach, Germany

Boehringer Ingelheim is seeking a dedicated and innovative postdoctoral scientist in the fields of cystic fibrosis (CF) and gene therapy at their research site in Biberach (Germany). The post-doc will explore the therapeutic potential of an advanced lentivirus gene therapy vector for the treatment of CF. The project will be part of a research collaboration between Boehringer Ingelheim and the UK Cystic Fibrosis Gene Therapy Consortium (GTC). Further information is available on the Boehringer Ingelheim website.